2 TOWER PLACE, SOUTH SAN FRANCISCO, CA
Reports Fourth Quarter and Full Year 2025 Financial Results
Amended material disclosure
Completes Sale of SomaLogic to Illumina
Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Reports Third Quarter 2025 Financial Results
Costs of Shutting Down or Selling Parts of the Business
Costs Associated with Exit or Disposal Activities
Reports Second Quarter 2025 Financial Results
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Contested Proxy Solicitation Materials
PRER14A
Preliminary Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Specialized Disclosure Report
Correspondence
Submission Upload